[go: up one dir, main page]

SG11201402042PA - Method of predicting breast cancer prognosis - Google Patents

Method of predicting breast cancer prognosis

Info

Publication number
SG11201402042PA
SG11201402042PA SG11201402042PA SG11201402042PA SG11201402042PA SG 11201402042P A SG11201402042P A SG 11201402042PA SG 11201402042P A SG11201402042P A SG 11201402042PA SG 11201402042P A SG11201402042P A SG 11201402042PA SG 11201402042P A SG11201402042P A SG 11201402042PA
Authority
SG
Singapore
Prior art keywords
breast cancer
cancer prognosis
predicting breast
predicting
prognosis
Prior art date
Application number
SG11201402042PA
Inventor
Joffre B Baker
Dominick V Sinicropi
Robert J Pelham
Michael Crager
Francois Collin
James C Stephans
mei-lan Liu
John Morlan
Kunbin Qu
Original Assignee
Genomic Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genomic Health Inc filed Critical Genomic Health Inc
Publication of SG11201402042PA publication Critical patent/SG11201402042PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57415Specifically defined cancers of breast
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/54Determining the risk of relapse
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Evolutionary Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
SG11201402042PA 2011-11-08 2012-11-02 Method of predicting breast cancer prognosis SG11201402042PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161557238P 2011-11-08 2011-11-08
US201261597426P 2012-02-10 2012-02-10
PCT/US2012/063313 WO2013070521A1 (en) 2011-11-08 2012-11-02 Method of predicting breast cancer prognosis

Publications (1)

Publication Number Publication Date
SG11201402042PA true SG11201402042PA (en) 2014-06-27

Family

ID=48290467

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202010758SA SG10202010758SA (en) 2011-11-08 2012-11-02 Method of predicting breast cancer prognosis
SG11201402042PA SG11201402042PA (en) 2011-11-08 2012-11-02 Method of predicting breast cancer prognosis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10202010758SA SG10202010758SA (en) 2011-11-08 2012-11-02 Method of predicting breast cancer prognosis

Country Status (9)

Country Link
US (4) US20140296085A1 (en)
EP (1) EP2776830B1 (en)
JP (2) JP6147755B2 (en)
AU (1) AU2012336120B2 (en)
CA (1) CA2854805C (en)
IL (4) IL232445B (en)
MX (1) MX357402B (en)
SG (2) SG10202010758SA (en)
WO (1) WO2013070521A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198972A1 (en) 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
US9856533B2 (en) 2003-09-19 2018-01-02 Biotheranostics, Inc. Predicting breast cancer treatment outcome
WO2012079059A2 (en) 2010-12-09 2012-06-14 Biotheranostics, Inc. Post-treatment breast cancer prognosis
WO2014044724A1 (en) * 2012-09-18 2014-03-27 Qiagen Gmbh Method and kit for preparing a target rna depleted sample
US10487362B2 (en) * 2013-01-09 2019-11-26 Health Research, Inc. Methods for diagnosing cancer based on small nucleolar RNA HBII-52
WO2014130444A1 (en) * 2013-02-19 2014-08-28 Genomic Health, Inc. Method of predicting breast cancer prognosis
WO2015038682A1 (en) * 2013-09-11 2015-03-19 bio Theranostics, Inc. Predicting breast cancer recurrence
EP3063689A4 (en) * 2013-10-29 2017-08-30 Genomic Health, Inc. Methods of incorporation of transcript chromosomal locus information for identification of biomarkers of disease recurrence risk
CN105214077B (en) * 2014-06-03 2019-02-05 浙江阿思科力生物科技有限公司 Application of the USP33 in tumour
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
RU2017124373A (en) * 2014-12-10 2019-01-10 Конинклейке Филипс Н.В. METHODS AND SYSTEM FOR CREATION OF COEXPRESSION NETWORKS OF NON-CODING AND CODING GENES
WO2017040526A2 (en) * 2015-09-01 2017-03-09 Eisai R&D Management Co., Ltd. Splice variants associated with neomorphic sf3b1 mutants
EP3365000B1 (en) 2015-10-23 2020-06-10 Novartis AG Method of deriving a value for percent biomarker positivity for selected cells present in a field of view
US11530448B2 (en) 2015-11-13 2022-12-20 Biotheranostics, Inc. Integration of tumor characteristics with breast cancer index
EP3202913B1 (en) * 2016-02-08 2019-01-30 King Faisal Specialist Hospital And Research Centre A set of genes for use in a method of predicting the likelihood of a breast cancer patient's survival
CA3063450A1 (en) * 2017-05-19 2018-11-22 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
US20190376115A1 (en) * 2018-06-08 2019-12-12 Glympse Bio, Inc. Activity sensor design
CN108893537B (en) * 2018-07-19 2020-10-30 青岛泱深生物医药有限公司 C7ORF70 and application thereof
JP2020028278A (en) * 2018-08-24 2020-02-27 国立大学法人九州大学 Method for generating classifier for predicting event occurring in subject, and method for stratifying subject using classifier
WO2020089691A1 (en) * 2018-11-04 2020-05-07 Pfs Genomics, Inc. Methods and genomic classifiers for prognosis of breast cancer and predicting benefit from adjuvant radiotherapy
CN109859801B (en) * 2019-02-14 2023-09-19 辽宁省肿瘤医院 Model for predicting lung squamous carcinoma prognosis by using seven genes as biomarkers and establishing method
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
WO2021216990A1 (en) * 2020-04-23 2021-10-28 Board Of Regents, The University Of Texas System Methods and compositions related to full-length excised intron rnas (flexi rnas)
EP4211468A4 (en) 2020-09-11 2024-10-09 Glympse Bio, Inc. EX-VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTICS, CLASSIFICATION, MONITORING AND TREATMENT
RU2763839C1 (en) * 2021-04-27 2022-01-11 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Петрова" Минздрава России) Method for multivariate prognosis of breast cancer
CN113667749A (en) * 2021-08-03 2021-11-19 广东省人民医院 A diagnostic kit for assessing breast cancer risk with a combination of four key genes
CN114480650A (en) * 2022-02-08 2022-05-13 深圳市陆为生物技术有限公司 Marker and model for predicting three-negative breast cancer clinical prognosis recurrence risk
CN114657242B (en) * 2022-03-16 2022-11-11 广州医科大学附属第一医院 Application of GPR33 gene in assessment of susceptible population of T. marneffei

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2799555B1 (en) * 2002-03-13 2017-02-22 Genomic Health, Inc. Gene expression profiling in biopsied tumor tissues
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
EP1651775A2 (en) * 2003-06-18 2006-05-03 Arcturus Bioscience, Inc. Breast cancer survival and recurrence
WO2005008213A2 (en) * 2003-07-10 2005-01-27 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
JP2005270093A (en) * 2004-02-24 2005-10-06 Nippon Medical School Genes involved in predicting postoperative prognosis of breast cancer
US20080299550A1 (en) * 2004-09-20 2008-12-04 Bayer Healthcare Ag Methods and Kits For the Prediction of Therapeutic Success and Recurrence Free Survival In Cancer Therapy
WO2008046182A1 (en) * 2006-09-15 2008-04-24 Mcgill University Stroma derived predictor of breast cancer
RU2473555C2 (en) * 2006-12-19 2013-01-27 ДжинГоу, Инк. New method for functional analysis of body of experimental data and gene groups identified from said data
EP2036988A1 (en) * 2007-09-12 2009-03-18 Siemens Healthcare Diagnostics GmbH A method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent
WO2009071655A2 (en) * 2007-12-06 2009-06-11 Siemens Healthcare Diagnostics Inc. Methods for breast cancer prognosis
US20110020370A1 (en) * 2008-12-11 2011-01-27 Elias Georges Slc7a5 directed diagnostics and therapeutics for neoplastic disease
CN101851611A (en) * 2009-04-01 2010-10-06 天津医科大学附属肿瘤医院 Metastasis-related function of kinesin-like protein KIF1B and its use as a marker for predicting the prognosis of tumor patients and its application method
WO2010127399A1 (en) * 2009-05-06 2010-11-11 Walter And Eliza Hall Institute Of Medical Research Gene expression profiles and uses thereof
US20120309640A1 (en) * 2009-10-08 2012-12-06 Torti Frank M Diagnostic and Prognostic Markers for Cancer
CA3043089A1 (en) * 2009-11-23 2011-05-26 Genomic Health, Inc. Methods to predict clinical outcome of cancer
EP2692871A1 (en) * 2009-12-01 2014-02-05 Compendia Bioscience, Inc. Classification of cancers
GB0922437D0 (en) * 2009-12-22 2010-02-03 Cancer Rec Tech Ltd Hypoxia tumour markers
US20130143753A1 (en) * 2010-03-01 2013-06-06 Adelbio Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom
EP2845911B1 (en) * 2010-03-31 2016-05-18 Sividon Diagnostics GmbH Method for breast cancer recurrence prediction under endocrine treatment

Also Published As

Publication number Publication date
MX2014005547A (en) 2014-08-29
IL261708A (en) 2018-10-31
EP2776830B1 (en) 2018-05-09
EP2776830A1 (en) 2014-09-17
IL232445A0 (en) 2014-06-30
IL276488B (en) 2021-04-29
JP2017055769A (en) 2017-03-23
JP2014532428A (en) 2014-12-08
US20160222463A1 (en) 2016-08-04
NZ624700A (en) 2016-08-26
US20140296085A1 (en) 2014-10-02
IL232445B (en) 2018-10-31
HK1201329A1 (en) 2015-08-28
MX357402B (en) 2018-07-09
IL265136B (en) 2020-08-31
IL276488A (en) 2020-09-30
AU2012336120B2 (en) 2017-10-26
CA2854805A1 (en) 2013-05-16
US20200263257A1 (en) 2020-08-20
EP2776830A4 (en) 2015-07-15
US20190256923A1 (en) 2019-08-22
SG10202010758SA (en) 2020-11-27
WO2013070521A1 (en) 2013-05-16
CA2854805C (en) 2021-04-27
JP6147755B2 (en) 2017-06-14
AU2012336120A1 (en) 2014-05-29

Similar Documents

Publication Publication Date Title
IL276488A (en) Method of predicting breast cancer prognosis
IL251403B (en) Method for using gene expression to determine prognosis of prostate cancer
GB201102014D0 (en) Method for predicting risk of developing cancer
EP2718721A4 (en) Circulating biomarkers for cancer
IL229319A0 (en) Biomarkers for lung cancer
SG10201704311VA (en) Methods for predicting risk of developing hypertension
GB2513275B (en) Biomarkers for Breast Cancer Prediction and Diagnosis
SG11201502778TA (en) Method of prognosis and stratification of ovarian cancer
EP2721180A4 (en) Genetic variants for predicting risk of breast cancer
HUE044184T2 (en) Improved method of ore processing
EP2668295A4 (en) Methods of detecting lung cancer
IL232493A0 (en) Method of quantifying cancer treatment
EP2739290A4 (en) Method for selection of chemotherapeutic agents for adenocarcinoma cancer
IL228636A0 (en) Biomarkers for predicting sensitivity to cancer treatments
SG11201402115TA (en) Methods for diagnosis and/or prognosis of gynecological cancer
GB2510539B (en) Biomarkers of cancer
EP2753716A4 (en) Novel risk biomarkers for lung cancer
EP2771695A4 (en) Method of breast cancer detection
EP2649225A4 (en) Biomarkers for prediction of breast cancer
EP2707720A4 (en) Diagnosis and prognosis of triple negative breast and ovarian cancer
IL214476A0 (en) Method for predicting breast and ovarian cancer risk
GB201107118D0 (en) Method of diagnosis and prognosis
EP2769225A4 (en) Predictive biomarkers for breast cancer
EP3060914A4 (en) Methods of determining breast cancer prognosis
EP2658992A4 (en) Protein biomarkers of late stage breast cancer